Evidence map›Paper›PMID 29326799›Full record

ArticleMediterranean journal of hematology and infectious diseases2018

Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India.

Nikhil Rabade, Goutham Raval, Shruti Chaudhary, P G Subramanian, Rohan Kodgule, Swapnali Joshi, Prashant Tembhare, Syed K Hasan, Hasmukh Jain, Manju Sengar and 6 more

Abstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. The Frequency, Clinico-Hematological Features, and Outcome of Acute Promyelocytic Leukemia with VariantIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Article
  3. Article
  4. Article
  5. [Analysis of fusion gene expression in acute myeloid leukemia].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2021
    Article
  6. PLZF-RARCancers · 2020
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Nikhil RabadeHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.
Goutham RavalHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.
Shruti ChaudharyHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.
P G SubramanianHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.
Rohan KodguleHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.
Swapnali JoshiHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.
Prashant TembhareHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.
Syed K HasanHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.
Hasmukh JainDepartment of Medical Oncology, Tata Memorial Centre, Mumbai.
Manju SengarDepartment of Medical Oncology, Tata Memorial Centre, Mumbai.
Gaurav NarulaDepartment of Medical Oncology, Tata Memorial Centre, Mumbai.
Shripad BanavaliDepartment of Medical Oncology, Tata Memorial Centre, Mumbai.
Pratibha Amare KadamDepartment of Cancer Cytogenetics, Tata Memorial Centre, Mumbai.
Dhanalaxmi ShettyDepartment of Cancer Cytogenetics, Tata Memorial Centre, Mumbai.
Sumeet GujralHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.
Nikhil PatkarHematopathology laboratory, Department of Pathology, Tata Memorial Centre, Mumbai.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Atypical breakpoints and variant APL cases involving alternative chromosomal aberrations are seen in a small subset of acute promyelocytic leukemia (APL) patients. Over seven different partner genes for RARA have been described. Although rare, these variants prove to be a diagnostic challenge and require a combination of advanced cytogenetic and molecular techniques for accurate characterization. Heterogeneity occurs not only at the molecular level but also at clinico-pathological level influencing treatment response and outcome. In this case series, we describe the molecular heterogeneity of APL with a focus on seven variant APL cases from a single tertiary cancer center in India over a period of two and a half years. We discuss five cases with

Indexed as

Acute promyelocytic leukemiaAPL rare translocationsAPL variantsMolecular subtypesZBT16-RARA fusion

Identifiers

PMID29326799
PMCPMC5760075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.